Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lupin Of India, Forest Of U.S. Allies To Market Medical Devices In U.S.

This article was originally published in PharmAsia News

Executive Summary

India's Lupin Laboratories and Forest Laboratories of the U.S. have agreed to share promotion and marketing of one of Lupin's medical devices in the United States. Forest's 50-person sales force is to be tapped to promote Lupin's Aerochamber products, such as AerochamberPlus, a valved holding chamber device with metered dose inhalers, to pediatricians. Lupin seeks to expand its presence in the U.S. respiratory market. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel